lithospermate b has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, H; Feng, Y; Liu, J; Shen, J; Wang, K; Xu, W; Zhu, N | 1 |
| Liu, J; Shen, JH; Wang, K; Zhang, QL; Zhao, J | 1 |
2 other study(ies) available for lithospermate b and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Magnesium lithospermate B ameliorates diabetic nephropathy by suppressing the uremic toxin formation mediated by gut microbiota.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Gastrointestinal Microbiome; Mice; Uremic Toxins | 2023 |
Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy.
Topics: Animals; Bile Acids and Salts; Computational Biology; Diabetic Nephropathies; Disease Models, Animal; Drugs, Chinese Herbal; Gastrointestinal Microbiome; Kidney Function Tests; Male; Mice; Mice, Inbred DBA | 2019 |